Atherosclerosis as a systemic feature of psoriasis

Authors


  • Conflict of interest: ABA received fellowships from The Dowling Club, Procter & Gamble, and received educational grants or acted as an investigator for Pfizer, Merck Serono, Basilea, LEO Pharma and Almirall. MP has received funding for research from Pfizer (formerly Wyeth). ADS and CCL have acted as paid consultants for Pzifer and have received funding for research. DJA received fees from Schering-Plough and Pfizer as an invited speaker.

Dr Anton B. Alexandroff, Department of Dermatology, Leicester Royal Infirmary, Infirmary Square, Leicester LE1 5WW, UK
E-mail: anton@alexandroff.org

No abstract is available for this article.

Ancillary